Clinical Trial Detail

NCT ID NCT03184870
Title A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb

pancreatic cancer

colorectal cancer


BMS-813160 + Fluorouracil + Irinotecan + Leucovorin

BMS-813160 + Nivolumab

BMS-813160 + Gemcitabine + Nab-paclitaxel


Age Groups: adult senior

No variant requirements are available.